MeetBridge is a B2B meeting marketplace where companies find and book qualified 30-minute video meetings with relevant business partners. Companies are matched by industry, geography, business intentions, and availability.

How does match scoring work?

Match scores evaluate compatibility across four dimensions: industry alignment, geographic focus overlap, mutual intent compatibility, and availability overlap. The result is a single percentage score showing how likely a meeting would be productive.

Is MeetBridge free to use?

Yes, MeetBridge offers a free plan with 22 points per month. New users get a 90-day free trial with 500 points (Pro-level access). The Pro plan costs $100/month for unlimited meetings and 500 points.

What types of businesses use MeetBridge?

MeetBridge serves brands, affiliates, agencies, publishers, SaaS providers, consultancies, and networks. The first vertical focuses on affiliate-brand partnerships, helping companies find qualified partners for performance marketing collaborations.

How do video meetings work on MeetBridge?

MeetBridge uses WebRTC peer-to-peer video calling built directly into the platform. Once both parties approve a meeting, they can join the 30-minute video call at the scheduled time without downloading any software.

How much does a meeting cost in points?

Searching for partners costs 2 points. Sending a meeting request costs 10 points. Approving a meeting costs 5 points. Both sides invest points, which ensures quality interactions and prevents spam.

Can I try MeetBridge before paying?

Absolutely. Every new account gets a 90-day free trial with 500 points per month — that's full Pro-level access with no credit card required.

What happens after a meeting?

After each meeting, both parties can optionally share their contact details (email and phone) and schedule follow-up meetings directly through the platform.

How is MeetBridge different from LinkedIn?

MeetBridge is purpose-built for qualified business meetings. Instead of generic connections and cold DMs, every interaction is intent-matched, scored for relevance, and gated by mutual agreement. You only meet partners who are genuinely relevant to your business.

Is my data safe on MeetBridge?

Yes. Passwords are encrypted, sessions are secured, and all connections use HTTPS. Contact details are only shared after you explicitly opt in following a completed meeting.

Epigenetic regulation of endocrine therapy resistance in breast cancer: A systems medicine approach to predict treatment outcome

SaaS Provider in Finance · Global · Unclaimed Profile

About Epigenetic regulation of endocrine therapy resistance in breast cancer: A systems medicine approach to predict treatment outcome

EU Funded (H2020) Research Project. Epigenetic regulation of endocrine therapy resistance in breast cancer: A systems medicine approach to predict treatment outcome is a saas provider specializing in financial services and fintech, including payments, banking, insurance, lending, and financial technology. The company connects with business partners across global markets across multiple continents through MeetBridge for meetings, partnerships, and collaborations.

Epigenetic regulation of endocrine therapy resistance in breast cancer: A systems medicine approach to predict treatment outcome is a saas provider operating in the financial services and fintech industry, including payments, banking, insurance, lending, and financial technology. With a global focus, Epigenetic regulation of endocrine therapy resistance in breast cancer: A systems medicine approach to predict treatment outcome serves clients and partners across multiple regions and markets.

As a saas provider in the finance space, Epigenetic regulation of endocrine therapy resistance in breast cancer: A systems medicine approach to predict treatment outcome is positioned to work with companies looking for Financial planning and analysis, Payment processing, Risk management and related capabilities. Once this profile is claimed by a company representative, businesses will be able to request meetings through MeetBridge.

Company Details

Company Name	Epigenetic regulation of endocrine therapy resistance in breast cancer: A systems medicine approach to predict treatment outcome
Business Type	SaaS Provider
Industry	Finance
Service Area	Global
Profile Status	Unclaimed — Sourced from public data
Website	http://redict.eu

Finance Services and Capabilities

Companies like Epigenetic regulation of endocrine therapy resistance in breast cancer: A systems medicine approach to predict treatment outcome in the finance industry typically provide the following types of services:

Financial planning and analysis
Payment processing
Risk management
Regulatory compliance
Accounting and bookkeeping
Invoice and billing
Treasury management
Financial reporting
Tax preparation
Audit services

The specific services offered by Epigenetic regulation of endocrine therapy resistance in breast cancer: A systems medicine approach to predict treatment outcome may vary. Claim this profile to add your specific services and start connecting with B2B partners.

Is this your company?

This profile for Epigenetic regulation of endocrine therapy resistance in breast cancer: A systems medicine approach to predict treatment outcome was created from publicly available information and hasn't been claimed yet. If you represent Epigenetic regulation of endocrine therapy resistance in breast cancer: A systems medicine approach to predict treatment outcome, claiming this profile allows you to:

Manage and update your company information
Receive and respond to B2B meeting requests
Connect with relevant partners matched by industry and intent
Access a free 90-day trial with full platform features

Claim Epigenetic regulation of endocrine therapy resistance in breast cancer: A systems medicine approach to predict treatment outcome on MeetBridge

Frequently Asked Questions about Epigenetic regulation of endocrine therapy resistance in breast cancer: A systems medicine approach to predict treatment outcome

What does Epigenetic regulation of endocrine therapy resistance in breast cancer: A systems medicine approach to predict treatment outcome do?

What services does Epigenetic regulation of endocrine therapy resistance in breast cancer: A systems medicine approach to predict treatment outcome offer?

Epigenetic regulation of endocrine therapy resistance in breast cancer: A systems medicine approach to predict treatment outcome is active in the financial services and fintech industry, including payments, banking, insurance, lending, and financial technology, which typically encompasses financial planning, payment processing, risk management, regulatory compliance, accounting. The specific services Epigenetic regulation of endocrine therapy resistance in breast cancer: A systems medicine approach to predict treatment outcome offers can be discussed in a direct meeting — request one through MeetBridge.

Is Epigenetic regulation of endocrine therapy resistance in breast cancer: A systems medicine approach to predict treatment outcome verified on MeetBridge?

Epigenetic regulation of endocrine therapy resistance in breast cancer: A systems medicine approach to predict treatment outcome's profile has not been claimed yet. The information shown is sourced from publicly available data. If you represent Epigenetic regulation of endocrine therapy resistance in breast cancer: A systems medicine approach to predict treatment outcome, you can claim this profile to verify and manage it.

How can I connect with Epigenetic regulation of endocrine therapy resistance in breast cancer: A systems medicine approach to predict treatment outcome for a partnership?

Epigenetic regulation of endocrine therapy resistance in breast cancer: A systems medicine approach to predict treatment outcome's profile on MeetBridge has not yet been claimed. Once a representative claims this profile, you'll be able to request B2B meetings directly through the platform.

What markets does Epigenetic regulation of endocrine therapy resistance in breast cancer: A systems medicine approach to predict treatment outcome serve?

Epigenetic regulation of endocrine therapy resistance in breast cancer: A systems medicine approach to predict treatment outcome focuses on worldwide, serving clients and partners across multiple continents and markets. Through MeetBridge, Epigenetic regulation of endocrine therapy resistance in breast cancer: A systems medicine approach to predict treatment outcome can connect with B2B partners both within their primary market and internationally.

What types of companies does Epigenetic regulation of endocrine therapy resistance in breast cancer: A systems medicine approach to predict treatment outcome work with?

As a saas provider in the Finance industry, Epigenetic regulation of endocrine therapy resistance in breast cancer: A systems medicine approach to predict treatment outcome typically works with companies across the finance space. Through MeetBridge, Epigenetic regulation of endocrine therapy resistance in breast cancer: A systems medicine approach to predict treatment outcome can be matched with the most relevant partners.

What industry does Epigenetic regulation of endocrine therapy resistance in breast cancer: A systems medicine approach to predict treatment outcome operate in?

Epigenetic regulation of endocrine therapy resistance in breast cancer: A systems medicine approach to predict treatment outcome operates in the financial services and fintech industry, including payments, banking, insurance, lending, and financial technology. This sector includes capabilities such as financial planning, payment processing, risk management, regulatory compliance, and more.

Is it free to contact Epigenetic regulation of endocrine therapy resistance in breast cancer: A systems medicine approach to predict treatment outcome on MeetBridge?

MeetBridge offers a free 90-day trial with 500 monthly points. Requesting a meeting costs points based on your plan. During the trial, you can contact Epigenetic regulation of endocrine therapy resistance in breast cancer: A systems medicine approach to predict treatment outcome and other companies at no charge. After the trial, a free plan or a Pro plan at $100/month keeps you connected to the network.

How should I prepare for a meeting with Epigenetic regulation of endocrine therapy resistance in breast cancer: A systems medicine approach to predict treatment outcome?

Before meeting with Epigenetic regulation of endocrine therapy resistance in breast cancer: A systems medicine approach to predict treatment outcome on MeetBridge, review their company profile and declared business intentions. Come prepared to explain your own role in the Finance space, what you're looking to achieve from the partnership, and why Epigenetic regulation of endocrine therapy resistance in breast cancer: A systems medicine approach to predict treatment outcome is a good fit for your goals. Meetings are 30 minutes — keep your introduction brief and focus on mutual value.

Similar Finance Companies on MeetBridge

Explore other finance companies in the MeetBridge directory that may be relevant for B2B partnerships:

Invalidenversicherung — Brand, Global
Swastik Merchant Finance Co. Ltd. — Brand, Global
Oak Investment Partners — Brand, Global
Selective Conversion of Water and CO2 Using Interfacial Electrochemical Engineering — Brand, Global
Assiniboine Credit Union — Brand, North America
Pacific Equity Partners — Brand, Australia
Biomolecule Sensing with Graphene-Integrated Nanogaps — Brand, Global
Champions First Credit Union — Brand, Global

Browse all companies in the MeetBridge directory

How MeetBridge Works

MeetBridge is a B2B meeting marketplace that helps companies discover and connect with relevant business partners through qualified 30-minute video meetings.

Create your company profile — Sign up for free, describe your business, industry, and what you're looking for in B2B partnerships.
Discover and match with partners — Our matching system scores companies by industry, geography, and mutual intent so you find the right fit fast.
Book a 30-minute video meeting — Pick an available time slot, explain why it's a good fit, and connect via built-in video call — no external tools needed.

MeetBridge offers a free 90-day trial with 500 points per month. After the trial, companies can continue with a free plan or upgrade to Pro ($100/month) for expanded access.